Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.7127 per EA under NDC 60219126401. Its NADAC has been published 169 times since Apr 5, 2023.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219126401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209093On Market Since
9/27/2022
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 169 times since Apr 5, 2023, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $1.4599 (Apr 12, 2023) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $0.9936 |
| Average price | $0.9728 |
| Largest weekly change | +34.1% (Jun 19, 2024) |
| Weeks tracked | 169 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.7127 per EA (NDC 60219126401), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 51.2%. It has been tracked across 169 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Apr 5, 2023, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $1.4599 (Apr 12, 2023), with a median of $0.9936 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 60219126401) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification